Bio-Rad Laboratories Inc (BIO)
Debt-to-equity ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 6,569,300 | 8,741,130 | 9,615,250 | 13,667,100 | 9,879,940 |
Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $6,569,300K
= 0.00
Bio-Rad Laboratories Inc has consistently maintained a debt-to-equity ratio of 0.00 across the years 2020 to 2024. This indicates that the company has not relied on debt to finance its operations and growth, opting instead for equity financing. A debt-to-equity ratio of 0.00 typically suggests a conservative financial structure, where the company has a low level of debt relative to its equity. This could signify a lower financial risk and a strong financial position, as the company is not burdened by high levels of debt obligations.
Peer comparison
Dec 31, 2024
Company name
Symbol
Debt-to-equity ratio
Bio-Rad Laboratories Inc
BIO
0.00
Avantor Inc
AVTR
0.54
Bruker Corporation
BRKR
1.16
Cytek Biosciences Inc
CTKB
0.00
Illumina Inc
ILMN
0.63
Mettler-Toledo International Inc
MTD
—
Revvity Inc.
RVTY
0.41
Waters Corporation
WAT
0.89